Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Dilling

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 16, 2019
Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosisMuhammad Umair Khawar, Dina Yazdani, Zheng Zhu, et al.
Alcoholism, Clinical and Experimental Research|November 26, 2014
Heavy alcohol use in lung donors increases the risk for primary graft dysfunctionErin M Lowery, Erica A Kuhlmann, Erin L Mahoney, et al.
American Journal of Respiratory Cell and Molecular Biology|September 24, 2011
A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment optionsDaniel F Dilling, Emily R Gilbert, Maria M Picken, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseasesJeffrey J Swigris, Kevin K Brown, Rayid Abdulqawi, et al.
Research Square|March 11, 2024
Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary FibrosisTejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
BMC Pulmonary Medicine|March 21, 2024
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosisTejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
Respiratory Medicine|March 11, 2022
A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplantKrishnan Warrior, Lorriana E Leard, Arun R Nair, et al.
Respiratory Investigation|January 11, 2024
Safety and efficacy of sirolimus in hospitalised patients with COVID-19 pneumoniaAbhishek Singla, Nusrat Harun, Daniel F Dilling, et al.
Annals of the American Thoracic Society|January 24, 2022
Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO RegistryAparna C Swaminathan, Anne S Hellkamp, Megan L Neely, et al.
American Journal of Respiratory Cell and Molecular Biology|February 21, 2020
Adoptive T-Cell Transfer to Treat LymphangioleiomyomatosisFei Han, Emilia R Dellacecca, Levi W Barse, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 16, 2019
Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosisMuhammad Umair Khawar, Dina Yazdani, Zheng Zhu, et al.
Alcoholism, Clinical and Experimental Research|November 26, 2014
Heavy alcohol use in lung donors increases the risk for primary graft dysfunctionErin M Lowery, Erica A Kuhlmann, Erin L Mahoney, et al.
American Journal of Respiratory Cell and Molecular Biology|September 24, 2011
A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment optionsDaniel F Dilling, Emily R Gilbert, Maria M Picken, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseasesJeffrey J Swigris, Kevin K Brown, Rayid Abdulqawi, et al.
Research Square|March 11, 2024
Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary FibrosisTejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
BMC Pulmonary Medicine|March 21, 2024
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosisTejaswini Kulkarni, Gerard J Criner, Daniel J Kass, et al.
Respiratory Medicine|March 11, 2022
A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplantKrishnan Warrior, Lorriana E Leard, Arun R Nair, et al.
Respiratory Investigation|January 11, 2024
Safety and efficacy of sirolimus in hospitalised patients with COVID-19 pneumoniaAbhishek Singla, Nusrat Harun, Daniel F Dilling, et al.
Annals of the American Thoracic Society|January 24, 2022
Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO RegistryAparna C Swaminathan, Anne S Hellkamp, Megan L Neely, et al.
American Journal of Respiratory Cell and Molecular Biology|February 21, 2020
Adoptive T-Cell Transfer to Treat LymphangioleiomyomatosisFei Han, Emilia R Dellacecca, Levi W Barse, et al.
Pageof 4